Early bird prices are coming to an end soon... ⏰ Grab your tickets before January 17

This article was published on April 23, 2020

VCs spent a record €8.2B in Europe in Q1 2020 — but coronavirus dampens future expectations


VCs spent a record €8.2B in Europe in Q1 2020 — but coronavirus dampens future expectations

Venture capital investors poured €8.2 billion into European companies during the first quarter of 2020.

According to PitchBook’s European Venture Report Q1 2020, the first three months of 2020 constituted the fourth-strongest quarter ever in terms of total deal value in Europe.

Although 2020 got off to a good start, the coronavirus pandemic is expected to have a significant impact on deals in the ecosystem. It also threatens the flow of US capital into European tech companies.

“We expect dealmaking to slow considerably in the next two quarters, however, as the repercussions of COVID-19 sweep across the globe. We believe the bull run sustained over the last decade may finally be coming to an end as wider economic outlooks considerably weaken,” the report reads.

The 💜 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol' founder Boris, and some questionable AI art. It's free, every week, in your inbox. Sign up now!

As gloomy as the prediction is, the report notes that dealmaking will not collapse but warns “this is the toughest economic challenge facing the venture ecosystem since the global financial crisis.”

The data also shows a particularly good quarter for European late-stage companies, as venture capital investors pumped €4.8 billion in Q1 — the third-highest quarterly figure on record.

Given the current climate, it’s plausible that VCs will not want to see their flagship portfolio companies fail. With this in mind, the report says there could be a shift in focus.

“We expect late-stage investments in existing portfolio companies to take priority over early-stage investments in the next year,” it reads.

As such, no sector appears completely immune from the pandemic.

The report goes on to specify that software startups have accounted for 42.6% of capital YTD and it’s likely this trend will continue.

As expected, there are also opportunities for startups that can facilitate remote collaboration and centralize essential business functions online.

Similarly, opportunities will also emerge for software startups focusing on personal cybersecurity, as scams and phishing attempts have reportedly increased and as companies look to improve their resilience against bad actors.

A spotlight on Europe’s healthcare ecosystem

The report says that healthcare startups received €1.7 billion from investors in Q1 2020.

If the current pace were to continue throughout 2020, the annual total would get close to the record €7.2 billion achieved last year.

Venture capital injection into healthcare companies in Europe.

“However, we believe healthcare VC deal activity is expected to slow as recessions bite into economies,” reads the report.

“The impact on healthcare investment could be less noticeable than in other sectors, as funding will be critical in combating the devastating pandemic,” it adds.

Startups focusing on technology-integrated solutions to assist with service provision, logistics, efficiency, and drug research have made popular investment strategies.

VC exit activity

VC exit activity

The first quarter of 2020 was not good for exits with these totalling €727.1 million and missing the €1 billion mark for the first quarter since Q4 2012.

“This represents a cautious exit market, which is likely to persist for the next few quarters. The impact of COVID-19 on exits is likely to be extensive, especially on IPOs and other types of liquidity that directly correlate to investor appetite and public equity performance,” says the report.

Acquisitions of Europe-based startups could attract a less expensive premium than US counterparts.

They could also be far more appealing to startups looking to penetrate the lucrative US tech sector, rather than partner with a less experienced Europe-based corporate

Europe’s fundraising progress

During the last five years, European fund sizes have grown to compete internationally as commitments from limited partners have also increased. 

Venture capital fundraising activity

While funds closed in Q1 2020 present optimism, new and active fundraising efforts will be suspended in the short term as coronavirus preads across Europe.

Those funds that did close in Q1 2020 are likely to have started and finished the capital raising process in the months before disruption descended upon Europe and the US.

“We expect fundraising levels to dip during the rest of 2020 as newly closed funds reduce in frequency,” the report estimates.

Corporate VCs

Elsewhere, corporate venture capital reached €3.4 billion during Q1 2020.

The report points out that the figure was lower than the quarterly average across 2019 and highlights that, unsurprisingly, it looks set to fall further throughout the rest of 2020.

Corporate venture capital activity

“As we enter the new decade and confront a global recession, the pressure on corporates will intensify. Volatile share prices, trimmed earnings and a lack of demand have already had an impact on growth targets and forced corporates to slash or remove dividend payments to save capital. Global economic downturns are felt faster in more liquid public equities, and as focus quickly shifts to protection of core assets and revenue streams, CVC investment is likely to fall consequently,” it says.

Startups in the home entertainment sector could see opportunities arise as people are advised to spend more time indoors.

For example, Berlin-based music streaming service SoundCloud closed a €67.9 million round from US-based radio broadcaster Sirius XM (NASDAQ: SIRI) in Q1 2020.

“The pandemic will no doubt shape future spending habits, and this could be an opportunity for CVCs to invest in services targeting online spending,” the report adds.

Get the TNW newsletter

Get the most important tech news in your inbox each week.

Also tagged with